Clinical Trial Update: A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in recurrent pediatric low-grade gliomas assessing Poly-ICLC; completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Brain Tumors
• Low-grade Glioma

Drugs mentioned

• Poly-ICLC (poly-ICLC)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Brain Tumors | Phase 2 | Status: COMPLETED | Results posted: 2023-04-03